U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07184918) titled 'Effect of Continuing vs. Discontinuing ACE Inhibitors on Renal Function After Coronary Angiography' on June 13.
Brief Summary: This clinical trial evaluates whether continuing or withholding ACE inhibitors (specifically Ramipril) before coronary angiography affects the risk of contrast-induced nephropathy (CIN). CIN is a known complication of iodinated contrast exposure, particularly in patients with chronic conditions such as hypertension or diabetes. The trial involves 44 adult patients randomized into two groups: one continuing Ramipril and the other withholding it 48 hours before and restarting 72 hours after the procedure. Ren...